The Chinese company will install a fill & finish plant in Chile that will produce more than 60 million doses of this vaccine and develop other vaccinations. It also announced that it will construct an R&D center in northern Chile.
FDI news | Policies & Tools | Business data analysis | Investment location trends
The Chinese company will install a fill & finish plant in Chile that will produce more than 60 million doses of this vaccine and develop other vaccinations. It also announced that it will construct an R&D center in northern Chile.
Topics: FDI- Chinese investment- Coronavirus- covid- Chinese companies in Chile- Science in Chile- Sinovac- biotech
Read MoreChilean scientists have discovered that an alpaca antibody blocks the Brazilian, British and South African variants of COVID-19. This is the same team of researchers that identified and produced neutralizing agents against SARS-CoV-2 from alpacas last year.
Topics: Human Capital- Innovation- Coronavirus- COVID-19- covid- STEM- Science in Chile- Talent
Read MoreGeneproDX has reached an agreement with Belgium’s Biocartis for the distribution of ThyroidPrint, a test that avoids unnecessary diagnostic surgeries and the permanent use of thyroid hormone supplements.
Topics: Innovation- Start-Up- Entrepreneurship- Science in Chile
Read MoreReceive in your e-mail publications and news about how to guide your investment project in Chile
100% Privacy. No Spam.